Skip to main content
SpringerLink
Log in

Pompholyx

A Review of Clinical Features, Differential Diagnosis, and Management

  • Review Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Pompholyx is a vesicobullous disorder of the palms and soles. The condition is hard to treat because of the peculiarities of the affected skin, namely the thick horny layer and richness of the sweat glands. In this article, we review the available therapies, and score the treatments according to the level of evidence.

The cornerstones of topical therapy are corticosteroids, although calcineurin inhibitors also seem to be effective. Topical photochemotherapy with methoxsalen (8-methoxypsoralen) is as effective as systemic photochemotherapy or high-dose UVA-1 irradiation.

Systemic therapy is often necessary in bullous pompholyx. Corticosteroids are commonly used although no controlled study has been published to date. For recalcitrant cases, corticosteroids are combined with immunosuppressants. Alitretinoin has efficacy in chronic hand dermatitis including pompholyx. Another evolving treatment seems to be the intradermal injection of botulinum toxin. Radiotherapy might be an option for selected patients not responding to conventional treatment. In practice, patients benefit most from a combination of treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Table I
Table II
Fig. 3
Table III
Table IV

Similar content being viewed by others

References

  1. Guillet MH, Wierzbicka E, Guillet S, et al. A 3-year causative study of pompholyx in 120 patients. Arch Dermatol 2007; 143 (12): 1504–8

    Article  PubMed  Google Scholar 

  2. Fox T. Dyshidrosis: “cheiro-pompholyx” [letter]. Lancet 1876; 1: 651

    Article  Google Scholar 

  3. Kutzner H, Wurzel RM, Wolff HH. Are acrosyringia involved in the pathogenesis of “dyshidrosis”? Am J Dermatopathol 1986; 8 (2): 109–16

    Article  PubMed  CAS  Google Scholar 

  4. Storrs FJ. Acute and recurrent vesicular hand dermatitis not pompholyx or dyshidrosis. Arch Dermatol 2007; 143 (12): 1578–80

    Article  PubMed  Google Scholar 

  5. Happle R. Paraptic eczema: why a new name? [in German]. Hautarzt 1994; 45 (1): 1–3

    Article  PubMed  CAS  Google Scholar 

  6. Wollina U, Abdel Naser MB. Pharmacotherapy of pompholyx. Expert Opin Pharmacother 2004; 5 (7): 1517–22

    Article  PubMed  CAS  Google Scholar 

  7. Tamer E, Ilhan MN, Polat M, et al. Prevalence of skin diseases among pediatric patients in Turkey. J Dermatol 2008; 35 (7): 413–8

    Article  PubMed  Google Scholar 

  8. Lee CS, Lim HW. Cutaneous diseases in Asians. Dermatol Clin 2003; 21 (4): 668–77

    Google Scholar 

  9. Chen JJ, Liang YH, Zhou FS, et al. The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1-18q22.3. J Invest Dermatol 2006; 126 (2): 300–4

    Article  PubMed  CAS  Google Scholar 

  10. Boettger MK, Bär KJ, Dohrmann A, et al. Increased vagal modulation in atopic dermatitis. J Dermatol Sci 2009; 53 (1): 55–9

    Article  PubMed  CAS  Google Scholar 

  11. Barbaud A, Reichert-Penetrat S, Trechot P, et al. Sensitization to resorcinol in a prescription verrucide preparation: unusual systemic clinical features and prevalence [in French]. Ann Dermatol Venereol 2001; 128 (5): 615–8

    PubMed  CAS  Google Scholar 

  12. Buckley DA, Keane FM, Munn SE, et al. Recalcitrant viral warts treated by diphencyprone immunotherapy. Br J Dermatol 1999; 141 (2): 292–6

    Article  PubMed  CAS  Google Scholar 

  13. Jain VK, Aggarwal K, Passi S, et al. Role of contact allergens in pompholyx. J Dermatol 2004; 31 (3): 188–93

    PubMed  Google Scholar 

  14. Meneghini CL, Angelini G. Contact and microbial allergy in pompholyx. Contact Dermatitis 1979; 5 (1): 46–50

    Article  PubMed  CAS  Google Scholar 

  15. Colebunders R, Zolfo M, Lynen L. Severe dyshidrosis in two patients with HIV infection shortly after starting highly active antiretroviral therapy. Dermatol Online J 2005; 11 (2): 31

    PubMed  Google Scholar 

  16. Uyttendaele H, Obadiah J, Grossmann M. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy. J Drugs Dermatol 2003; 2 (3): 337–41

    PubMed  Google Scholar 

  17. Hindsen M, Bruze M, Christensen OB. Individual variation in nickel patch test reactivity. Am J Contact Dermat 1999; 10 (2): 62–7

    Article  PubMed  CAS  Google Scholar 

  18. Adachi A, Horikawa T. Pompholyx of the infant possibly induced by systemic metal allergy to chromium in mother’s milk [in Japanese]. Aerugi 2007; 56 (7): 703–8

    Google Scholar 

  19. Semhoun-Ducloux S, Ducloux D, Mignet JP. Mycophenolate mofetil-induced dyshidrotic eczema [letter]. Ann Intern Med 2000; 132 (5): 417

    PubMed  CAS  Google Scholar 

  20. Möller H, Spirén A, Svensson A, et al. Contact allergy to the Asteraceae plant Ambrosia artemisiifolia L (ragweed) in sesquiterpene lactone-sensitive patients in southern Sweden. Contact Dermatitis 2002; 47 (3): 157–60

    Article  PubMed  Google Scholar 

  21. Braunstein BL. Dyshidrotic eczema associated with piroxicam photosensitivity. Cutis 1985; 35 (5): 485–6

    PubMed  CAS  Google Scholar 

  22. Lazzarini R, Duarte I, Marzagao C. Contact dermatitis of the feet: a study of 53 cases. Dermatitis 2004; 15 (3): 125–30

    Article  PubMed  Google Scholar 

  23. Grange‐Prunier A, Bezier M, Perceau G, et al. Tobacco contact dermatitis caused by sensitivity to sorbic acid [in French]. Ann Dermatol Venereol 2008; 135 (2): 135–8

    Article  PubMed  Google Scholar 

  24. Gawkrodger DJ, Cook SW, Fell GS, et al. Nickel dermatitis: the reaction to oral nickel challenge. Br J Dermatol 1986; 115 (1): 33–8

    Article  PubMed  CAS  Google Scholar 

  25. Bryld LE, Agner T, Menné T. Relation between vesicular eruptions on the hands and tinea pedis, atopic dermatitis and nickel allergy. Acta Derm Venereol 2003; 83 (3): 186–8

    Article  PubMed  Google Scholar 

  26. Pitché P, Boukari M, Tchangai-Walla K. Factors associated with palmoplantar or plantar pompholyx: a case-control study [in French]. Ann Dermatol Venereol 2006; 133 (2): 139–43

    Article  PubMed  Google Scholar 

  27. Nowicki R. Allergic phenomena in the course of dermatomycoses [in Polish]. Pol Merkur Lekraski 2003; 14 (84): 532–4

    Google Scholar 

  28. MacConnachie AA, Smith CC. Pompholyx as a manifestation of HIV infection, response to antiretroviral therapy. Acta Derm Venereol 2007; 87 (4): 378–9

    Article  PubMed  Google Scholar 

  29. Niinai H, Kawamoto M, Yuge O. Severe pompholyx following endoscopic thoracic sympathectomy for palmar hyperhidrosis. Interact Cardiovasc Thorac Surg 2004; 3 (4): 593–5

    Article  PubMed  Google Scholar 

  30. Douwes KE, Karrer S, Abels C, et al. Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar hand eczema? Photodermatol Photoimmunol Photomed 2000; 16 (1): 25–9

    Article  PubMed  CAS  Google Scholar 

  31. Hirayama M. Sweating dysfunctions in Parkinson’s disease. J Neurol 2006; 253 (Suppl. 7): VII42–7

    Google Scholar 

  32. Man I, Ibbotson SH, Fergusan J. Photoinduced pompholyx: a report of 5 cases. J Am Acad Dermatol 2004; 50 (1): 55–60

    Article  PubMed  Google Scholar 

  33. Braun-Falco M, Schnopp C, Abeck D. Palmoplantar vesicular lesions in childhood [in German]. Hautarzt 2003; 54 (2): 156–9

    PubMed  CAS  Google Scholar 

  34. Stoyama M, Yamamoto S, Kanzaki T. Adult T-cell leukaemia/lymphoma presenting with digital gangrene. Dermatology 1997; 195 (2): 150–2

    Article  Google Scholar 

  35. Cole C, Gazewood J. Diagnosis and treatment of impetigo. Am Fam Physicians 2007; 75 (6): 859–64

    Google Scholar 

  36. Heéliot I, Beylot-Barry M, Vergier B, et al. Cutaneous T-cell lymphoma bullosa: 2 cases [in French]. Ann Dermatol Venereol 2003; 130 (6-7): 639–42

    Google Scholar 

  37. Sugimura C, Katsuura J, Motiue T, et al. Dyshidrosiform pemphigoid: report of a case. J Dermatol 2003; 30 (7): 525–9

    PubMed  Google Scholar 

  38. Duhra P, Charles-Holmes R. Linear IgA disease with haemorrhagic pompholyx and dapsone-induced neutropenia. Br J Dermatol 1991; 125 (2): 172–4

    Article  PubMed  CAS  Google Scholar 

  39. Uitto J. Epidermolysis bullosa: prospects for cell-mediated therapies. J Invest Dermatol 2008; 128 (9): 2140–2

    Article  PubMed  CAS  Google Scholar 

  40. Parillo SJ. Stevens‐Johnsons syndrome and toxic epidermal necrolysis. Curr Allery Asthma Rep 2007; 7 (4): 243–7

    Article  Google Scholar 

  41. Sutton‐Hayes S, Weisse ME, Wilson NW, et al. A recurrent presentation of hand, foot and mouth disease. Clin Pediatr (Phila) 2006; 45 (4): 376–7

    Google Scholar 

  42. Fletcher PG, Sterling JG. Recurrent herpes simplex virus type 2 infection of the hand complicated by persistent lymphoedema. Australas J Dermatol 2005; 46 (2): 110–3

    Article  PubMed  Google Scholar 

  43. Whittaker SJ, Ng YL, Rustin M, et al. HTLV-1-associated cutaneous disease: a clinicopathological and molecular study of patients from the U.K. Br J Dermatol 1993; 128 (5): 483–92

    Article  PubMed  CAS  Google Scholar 

  44. Gupta R. Drugs causing fixed drug eruptions: confirmed by provocation tests [letter]. Indian J Dermatol Venereol Leprol 2003; 69 (2): 120–1

    PubMed  CAS  Google Scholar 

  45. Wollina U. Disorders caused by physical and chemical damage. In: Braun-Falco O, Plewig G, Wolff HH, et al., editors. Dermatology and venerology. 6th ed. Heidelberg, New York: Springer, 2007: 571–85

    Google Scholar 

  46. Borradori L, Harms M. Podopompholyx due to pemphigus vulgaris and Trichophyton rubrum infection: report of an unusual case. Mycoses 1994; 37 (3-4): 137–9

    Article  PubMed  CAS  Google Scholar 

  47. Normand F, Armingaud P, Este`ve E. Dyshidrosis and acral purpura during polymorphic dermatitis in pregnancy: 2 cases. Ann Dermatol Venereol 2001; 128 (4): 531–3

    PubMed  CAS  Google Scholar 

  48. Barta U, Wollina U. Psoriasis der Haut. In: Wollina U, Hein G, Knopf B, editors. Psoriasis und Gelenkerkrankungen: Pathogenese, Klinik, Diagnostik und Therapie der psoriatischen Osteoarthropathie. Jena: Gustav Fischer Verlag, 1996: 38–48

    Google Scholar 

  49. Berbis P. Palmoplantar pustulosis [in French]. Rev Prat 1991; 41 (22): 2165–8

    PubMed  CAS  Google Scholar 

  50. Cheng S, Edmonds E, Ben-Gashir M, et al. Subcorneal pustular dermatosis 50 years on. Clin Exp Dermatol 2008; 33 (3): 220–33

    Article  Google Scholar 

  51. Duhra P, Ryatt KS. Haemorrhagic pompholyx in bullous pemphigoid. Clin Exp Dermatol 1988; 13 (5): 342–3

    Article  PubMed  CAS  Google Scholar 

  52. Barth JH, Venning VA, Wojnarowska F. Palmoplantar involvement in autoimmune blistering disorders: pemphigoid, linear IgA disease and herpes gestationis. Clin Exp Dermatol 1988; 13 (2): 85–6

    Article  PubMed  CAS  Google Scholar 

  53. Vocks E, Plotz SG, Ring J. The Dyshidrotic Eczema Area and Severity Index: a score developed for the assessment of dyshidrotic eczema. Dermatology 1999; 198 (3): 265–9

    Article  PubMed  CAS  Google Scholar 

  54. Veien NK, Ølholm Larsen P, Thestrup-Pedersen K, et al. Long-term, intermittent treatment of chronic hand eczema with mometasone fuorate. Br J Dermatol 1999; 140 (5): 882–6

    Article  PubMed  CAS  Google Scholar 

  55. Harper J. Topical corticosteroids for skin disorders in infants and children. Drugs 1988; 36 Suppl. 5: 34–7

    Article  PubMed  Google Scholar 

  56. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol 1992; 72 (1): 69–71

    PubMed  CAS  Google Scholar 

  57. Schnopp C, Remling R, Möhrenschläger M, et al. Topical tacrolimus (FK 506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002; 46 (1): 73–7

    Article  PubMed  Google Scholar 

  58. Schurmeyer-Horst F, Luger T, Böhm M. Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema [letter]. Dermatology 2007; 214 (1): 99–100

    Article  PubMed  Google Scholar 

  59. Belsito DV, Fowler Jr JF, Marks Jr JG, et al. Multicenter Investigator Group: pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004; 73 (1): 31–8

    PubMed  Google Scholar 

  60. Hanifin JM, Stevens V, Sheth P, et al. Novel treatment of chronic severe hand dermatitis with bexarotene gel. Br J Dermatol 2004; 105 (3): 545–53

    Article  Google Scholar 

  61. Scerri L. Azathioprine in dermatological practise: an overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv Exp Med Biol 1999; 455: 343–8

    Article  PubMed  CAS  Google Scholar 

  62. Egan CA, Rallis TM, Meadows KP, et al. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999; 40 (4): 612–4

    Article  PubMed  CAS  Google Scholar 

  63. Pickenacker A, Luger TA, Schwarz T. Dyshidrotic eczema treated with mycophenolate mofetil. Arch Dermatol 1998; 134 (3): 378–9

    Article  PubMed  CAS  Google Scholar 

  64. Reitamo S, Granlund H. Cyclosporin A in the treatment of chronic dermatitis of the hands. Br J Dermatol 1994; 130 (1): 75–8

    Article  PubMed  CAS  Google Scholar 

  65. Cheer SM, Foster RH. Alitretinoin. Am J Clin Dermatol 2000; 1 (5): 307–14

    Article  PubMed  CAS  Google Scholar 

  66. Ruzicka T, Larsen FG, Galewicz D, et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004; 140 (12): 1453–9

    Article  PubMed  CAS  Google Scholar 

  67. Ruzicka T, Lynde CW, Jemec GBE, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized doubleblind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158 (4): 808–17

    Article  PubMed  CAS  Google Scholar 

  68. Ogden S, Clayton TH, Goodfield MJD. Recalcitrant hand pompholyx: variable response to etanercept. Clin Exp Dermatol 2005; 31 (1): 145–6

    Article  Google Scholar 

  69. Pigatto PD, Gibelli E, Fumagalli M, et al. Disodium cromoglycate versus diet in the treatment and prevention of nickel-positive pompholyx. Contact Dermatitis 1990; 22 (1): 27–31

    Article  PubMed  CAS  Google Scholar 

  70. Wollina U, Karamfilov T. Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison. J Eur Acad Dermatol Venereol 2002; 16 (1): 40–2

    Article  PubMed  CAS  Google Scholar 

  71. Swartling C, Naver H, Lindberg M, et al. Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin. J Am Acad Dermatol 2002; 47 (5): 667–71

    Article  PubMed  Google Scholar 

  72. Bansal C, Omlin KJ, Hayes CM, et al. Novel cutaneous uses for botulinum toxin type A. J Cosmet Dermatol 2006; 5 (3): 268–72

    Article  PubMed  Google Scholar 

  73. Kontochritopoulos G, Gregoriou S, Agiasofitou G, et al. Regression of relapsing dyshidrotic eczema after treatment of concomitant hyperhidrosis with botulinum toxin-A [letter. Dermatol Surg 2007; 33 (10): 1289–90

    Article  Google Scholar 

  74. Hunziker T, Haudenschild-Falb E, Schmidli J, et al. “Aqua-SUP” in chronic palmoplantar dermatoses [in German]. Hautarzt 1987; 38 (3): 165–7

    PubMed  CAS  Google Scholar 

  75. Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol 2000; 25 (7): 552–8

    Article  PubMed  CAS  Google Scholar 

  76. Grundmann-Kollmann M, Behrens S, Peter RU, et al. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 1999; 15 (2): 87–9

    Article  PubMed  CAS  Google Scholar 

  77. Grattan CE, Carmichael AJ, Shuttleworth GJ, et al. Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm Venereol 1991; 71 (2): 118–22

    PubMed  CAS  Google Scholar 

  78. Schmidt T, Abeck D, Boeck K, et al. UVA1 irradiation is effective in treatment of chronic vesicular hand eczema. Acta Derm Venereol 1998; 78 (4): 318–9

    Article  PubMed  CAS  Google Scholar 

  79. Polderman MC, Govaert JC, le Cessie S, et al. A double-blind placebocontrolled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 2003; 28 (6): 584–7

    Article  PubMed  CAS  Google Scholar 

  80. Petering H, Breuer C, Herbst R, et al. Comparision of localized high-dose UVA1 versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 2004; 50 (1): 68–72

    Article  PubMed  Google Scholar 

  81. Jansen GT. Grenz rays: adequate or antiquated? J Dermatol Surg Oncol 1978; 4 (8): 627–9

    PubMed  CAS  Google Scholar 

  82. Stambaugh MD, Denittis AS, Wallner PE, et al. Complete remission of refractory dyshidrotic eczema with the use of radiation therapy. Cutis 2000; 65 (4): 211–4

    PubMed  CAS  Google Scholar 

  83. Odia S, Vocks E, Rakoski J, et al. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed current. Acta Derm Venereol 1996; 76 (6): 472–4

    PubMed  CAS  Google Scholar 

  84. Wollina U, Uhlemann C, Elstermann D, et al. Therapy of hyperhidrosis with tap water iontophoresis: positive effect on healing time and lack of recurrence in hand-foot eczema [in German]. Hautarzt 1998; 49 (2): 109–13

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergology, Academic Teaching Hospital Dresden Friedrichstadt, 01067, Friedrichstrasse 41, Dresden, Germany

    Uwe Wollina

Authors
  1. Uwe Wollina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe Wollina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wollina, U. Pompholyx. Am J Clin Dermatol 11, 305–314 (2010). https://doi.org/10.2165/11533250-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11533250-000000000-00000

Keywords

Search

Navigation